Anbio Biotechnology: pretax_income
| Value | {"amount": 2372842, "concept": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3ae2b030-3881-42a9-ae16-792b37f826c7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-035802Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001982708/pretax-income/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3ae2b030-3881-42a9-ae16-792b37f826c7
History
- no predecessors — first report